Email updates

Keep up to date with the latest news and content from Experimental Hematology and Oncology and BioMed Central.

Open Access Editorial

Publish, not perish: Introducing Experimental Hematology & Oncology

Zihai Li1*, Chung-Tsen Hsueh2 and Delong Liu3

Author Affiliations

1 Department of Microbiology & Immunology, Medical University of South Carolina, Charlston, SC 29425, USA

2 Loma Linda University Medical Center, Loma Linda, CA 92354, USA

3 New York Medical College, Valhalla, NY 10595, USA

For all author emails, please log on.

Experimental Hematology & Oncology 2012, 1:1  doi:10.1186/2162-3619-1-1

Published: 26 March 2012


As a scientific discipline, medicine can only be advanced by experimentation. Experimentation could either validate or refute a hypothesis. Unfortunately, today's publication climate strongly favors publication of positive research findings, especially with clinical trials. Experimental Hematology & Oncology (eHO) is a new open access online journal that emphasizes preclinical, patient-oriented and translational aspects of research. The journal differentiates from others in the field by making a deliberate effort in publishing clinical trials with "negative" results and basic science studies with provocative findings. The focus of the peer-review mechanism for eHO will be on the technical merit of the study and not on demanding a long list of additional experiments that hinders rapid information dissemination.